Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesis

Naseem Ansari, Satish Srivastava

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Rats fed a high galactose (30% galactose) diet ( w w) or made diabetic by injecting streptozotocin developed mature cataracts in approximately 45 and 90 days, respectively. Addition of allopurinol, a commonly used drug in the therapy of gout, to the high galactose diet or to the normal diet fed to diabetic rats advanced cataractogenesis in both the groups by approximately 50%. Allopurinol fed to control rats did not cause cataract formation. Feeding butylated hydroxy toluene (BHT), an antioxidant, prevented the allopurinol-induced advancement of cataract formation in galactosemic and diabetic rats. Assuming that these results are applicable in human subjects, there is need for caution in using allopurinol for the therapy of gout in diabetic subjects.

Original languageEnglish (US)
Pages (from-to)939-943
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume168
Issue number3
DOIs
StatePublished - May 16 1990

Fingerprint

Allopurinol
Toluene
Sugars
Nutrition
Galactose
Cataract
Rats
Gout
Diet
Rat control
Streptozocin
Antioxidants
Drug Therapy
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesis. / Ansari, Naseem; Srivastava, Satish.

In: Biochemical and Biophysical Research Communications, Vol. 168, No. 3, 16.05.1990, p. 939-943.

Research output: Contribution to journalArticle

@article{06616fe575fd47c1afb23162eaa55825,
title = "Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesis",
abstract = "Rats fed a high galactose (30{\%} galactose) diet ( w w) or made diabetic by injecting streptozotocin developed mature cataracts in approximately 45 and 90 days, respectively. Addition of allopurinol, a commonly used drug in the therapy of gout, to the high galactose diet or to the normal diet fed to diabetic rats advanced cataractogenesis in both the groups by approximately 50{\%}. Allopurinol fed to control rats did not cause cataract formation. Feeding butylated hydroxy toluene (BHT), an antioxidant, prevented the allopurinol-induced advancement of cataract formation in galactosemic and diabetic rats. Assuming that these results are applicable in human subjects, there is need for caution in using allopurinol for the therapy of gout in diabetic subjects.",
author = "Naseem Ansari and Satish Srivastava",
year = "1990",
month = "5",
day = "16",
doi = "10.1016/0006-291X(90)91119-D",
language = "English (US)",
volume = "168",
pages = "939--943",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Allopurinol promotes and butylated hydroxy toluene prevents sugar-induced cataractogenesis

AU - Ansari, Naseem

AU - Srivastava, Satish

PY - 1990/5/16

Y1 - 1990/5/16

N2 - Rats fed a high galactose (30% galactose) diet ( w w) or made diabetic by injecting streptozotocin developed mature cataracts in approximately 45 and 90 days, respectively. Addition of allopurinol, a commonly used drug in the therapy of gout, to the high galactose diet or to the normal diet fed to diabetic rats advanced cataractogenesis in both the groups by approximately 50%. Allopurinol fed to control rats did not cause cataract formation. Feeding butylated hydroxy toluene (BHT), an antioxidant, prevented the allopurinol-induced advancement of cataract formation in galactosemic and diabetic rats. Assuming that these results are applicable in human subjects, there is need for caution in using allopurinol for the therapy of gout in diabetic subjects.

AB - Rats fed a high galactose (30% galactose) diet ( w w) or made diabetic by injecting streptozotocin developed mature cataracts in approximately 45 and 90 days, respectively. Addition of allopurinol, a commonly used drug in the therapy of gout, to the high galactose diet or to the normal diet fed to diabetic rats advanced cataractogenesis in both the groups by approximately 50%. Allopurinol fed to control rats did not cause cataract formation. Feeding butylated hydroxy toluene (BHT), an antioxidant, prevented the allopurinol-induced advancement of cataract formation in galactosemic and diabetic rats. Assuming that these results are applicable in human subjects, there is need for caution in using allopurinol for the therapy of gout in diabetic subjects.

UR - http://www.scopus.com/inward/record.url?scp=0025306966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025306966&partnerID=8YFLogxK

U2 - 10.1016/0006-291X(90)91119-D

DO - 10.1016/0006-291X(90)91119-D

M3 - Article

VL - 168

SP - 939

EP - 943

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -